Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).

Kim, Wook; Kim, Hyung-Ho; Han, Sang-Uk; Kim, Min-Chan; Hyung, Woo Jin; Ryu, Seung Wan; Cho, Gyu Seok; Kim, Chan Young; Yang, Han-Kwang; Park, Do Joong; Song, Kyo Young; Lee, Sang Il; Ryu, Seung Yub; Lee, Joo-Ho; Lee, Hyuk-Joon
Annals of surgery
2016Jan ; 263 ( 1 ) :28-35.
ÀúÀÚ »ó¼¼Á¤º¸
Kim, Wook -
Kim, Hyung-Ho -
Han, Sang-Uk -
Kim, Min-Chan -
Hyung, Woo Jin -
Ryu, Seung Wan -
Cho, Gyu Seok -
Kim, Chan Young -
Yang, Han-Kwang -
Park, Do Joong -
Song, Kyo Young -
Lee, Sang Il -
Ryu, Seung Yub -
Lee, Joo-Ho -
Lee, Hyuk-Joon -
ABSTRACT
OBJECTIVE: To determine the safety of laparoscopy-assisted distal gastrectomy (LADG) compared with open distal gastrectomy (ODG) in patients with clinical stage I gastric cancer in Korea. BACKGROUND: There is still a lack of large-scale, multicenter randomized trials regarding the safety of LADG.

METHODS: A large-scale, phase 3, multicenter, prospective randomized controlled trial was conducted. The primary end point was 5-year overall survival. Morbidity within 30 postoperative days and surgical mortality were compared to evaluate the safety of LADG as a secondary end point

RESULTS: : A total of 1416 patients were randomly assigned to the LADG group (n = 705) or the ODG group (n = 711) between February 1, 2006, and August 31, 2010, and 1384 patients were analyzed for modified intention-to-treat analysis (ITT) and 1256 were eligible for per protocol (PP) analysis (644 and 612, respectively). In the PP analysis, 6 patients (0.9%) needed open conversion in the LADG group. The overall complication rate was significantly lower in the LADG group (LADG vs ODG; 13.0% vs 19.9%, P = 0.001). In detail, the wound complication rate of the LADG group was significantly lower than that of the ODG group (3.1% vs 7.7%, P < 0.001). The major intra-abdominal complication (7.6% vs 10.3%, P = 0.095) and mortality rates (0.6% vs 0.3%, P = 0.687) were similar between the 2 groups. Modified ITT analysis showed similar results with PP analysis.

CONCLUSIONS: LADG for patients with clinical stage I gastric cancer is safe and has a benefit of lower occurrence of wound complication compared with conventional ODG.
complication, laparoscopy, morbidity, mortality, stomach neoplasm
MESH
Feasibility Studies, Female, Gastrectomy/*adverse effects/*methods, Humans, Laparoscopy/*adverse effects, Male, Middle Aged, Neoplasm Staging, Postoperative Complications/epidemiology/etiology, Prospective Studies, Stomach Neoplasms/pathology/*surgery, Time Factors, Treatment Outcome
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
LADG for patients with clinical stage I gastric cancer is safe and has a benefit of lower occurrence of wound complication compared with conventional ODG.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1097/SLA.0000000000001346.
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå